Robinson James A. Jr.
SEC-identified person · CIK 1734295 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Urogen Pharma Ltd. URGN | Director | filed 2023 - 2026 |
| Tokai Pharmaceuticals Inc TKAI | Director | filed 2023 - 2026 |
| Applied Genetic Technologies Corp AGTC | Director | filed 2021 - 2022 |
| Urovant Sciences Ltd. UROV | Director · PEO;CEO/Urovant Sciences, Inc. | filed 2019 - 2021 |
| Neos Therapeutics, Inc. NEOS | Director | filed 2019 - 2021 |
| Alkermes plc. ALKS | President & COO,Alkermes, Inc. | filed 2018 - 2019 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.